The Food Standards Australia New Zealand (FSANZ) has granted approval for the use of Vitamin K2 in Food for Special Medical Purposes (FSMP), a significant advancement for medical nutrition. This decision reflects the growing understanding of Vitamin K2’s role as a vital nutrient for individuals with specific medical or nutritional requirements.
MenaQ7® – A Trusted, Clinically Supported Vitamin K2
At the forefront of this category is MenaQ7®, a patented and extensively researched brand of Vitamin K2 (Menaquinone-7, or MK-7). Renowned for its excellent bioavailability and extended half-life, MenaQ7® supports the activation of calcium-binding proteins that help channel calcium to bones and away from arteries. While Vitamin K1 primarily supports blood coagulation, Vitamin K2’s ability to support bone and cardiovascular health makes it especially relevant for elderly individuals, patients with osteoporosis, and those at risk of arterial calcification.
Opening New Possibilities for Clinical Nutrition
This FSANZ approval allows healthcare providers and medical nutrition companies to formulate FSMP products that include Vitamin K2, helping to meet the targeted nutritional demands of patients under medical supervision. The inclusion of MenaQ7® in such products offers a scientifically backed solution to support bone density, vascular flexibility, and long-term health outcomes.
As scientific awareness continues to expand around the importance of Vitamin K2, this regulatory milestone paves the way for broader adoption of effective, targeted nutrition in the clinical setting.
Do you need more information about Vitamin K2 or have any outstanding questions? Please do not hesitate to contact us; our expert team will happily answer!